|
MTHFD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.710200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.343600E-01 |
| Normal-vs-Stage2 |
4.289600E-01 |
| Normal-vs-Stage3 |
7.564600E-01 |
| Normal-vs-Stage4 |
7.869400E-01 |
| Stage1-vs-Stage2 |
9.554000E-01 |
| Stage1-vs-Stage3 |
5.725800E-01 |
| Stage1-vs-Stage4 |
7.491200E-01 |
| Stage2-vs-Stage3 |
6.567400E-01 |
| Stage2-vs-Stage4 |
7.764000E-01 |
| Stage3-vs-Stage4 |
9.706400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.566800E-01 |
| Normal-vs-AfricanAmerican |
9.518100E-02 |
| Normal-vs-Asian |
3.323000E-01 |
| Caucasian-vs-AfricanAmerican |
2.206400E-01 |
| Caucasian-vs-Asian |
5.910000E-01 |
| AfricanAmerican-vs-Asian |
8.963600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.269400E-01 |
| Normal-vs-Female |
4.726600E-01 |
| Male-vs-Female |
8.151800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.755700E-02 |
| Normal-vs-Extreme_Weight |
1.324760E-01 |
| Normal-vs-Obese |
8.706000E-01 |
| Normal-vs-Extreme_Obese |
9.558400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.470400E-01 |
| Normal_Weight-vs-Obese |
1.052590E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.825400E-01 |
| Extreme_Weight-vs-Obese |
1.276980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.229000E-01 |
| Obese-vs-Extreme_Obese |
8.687400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.019000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.224600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.653400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.705000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.275800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.836000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.101000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.210200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.623400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.873370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.126600E-01 |
| Normal-VS-Type2 PRCC |
7.637000E-01 |
| Normal-VS-KIRP CIMP |
3.172200E-01 |
| Normal-VS-Unclassified PRCC |
6.133400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.013570E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.554600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.356800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.793800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.324000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.569800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.724200E-01 |
| Normal-vs-N1 |
5.471600E-01 |
| Normal-vs-N2 |
2.366200E-02 |
| N0-vs-N1 |
1.392180E-01 |
| N0-vs-N2 |
1.542630E-01 |
| N1-vs-N2 |
6.148200E-02 |
|
|
